Conference on Retroviruses and Opportunistic Infections, Virtual & In-Person February 12-16 2022

Poster presentation:

• Trends in cancer incidence in different modern ART-eras among people living with HIV presented by Amanda Mocroft on behalf of the RESPOND Study Group. POSTER
   
• HIV/HBV/HCV triple infection, end stage liver disease and all-cause mortality presented by Amanda Mocroft on behalf of EuroSIDA Study Group. POSTER
   

12th International Workshop on HIV & Women, Virtual, 6-8 April 2022

Poster presentation:

• Characteristics of Women Living with HIV in the RESPOND Cohort presented by Jolie Hutchinson on behalf of the RESPOND Study Group. POSTER
   

Australian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) conference, 29 August - 1 September 2022

Oral presentation:

• Characteristics of Women Living with HIV in the RESPOND Cohort presented by Jolie Hutchinson on behalf of the RESPOND Study Group. PRESENTATION
   

HIV Glasgow 2022, 23-26 October 2022

Oral presentation:

• Risk of tuberculosis after initiation of antiretroviral therapy among people living with HIV in Europe presented by Isik Somuncu Johansen on behalf of the RESPOND Study Group. POSTER and PRESENTATION
   
• Use of Preventive Measures for Cardiovascular Disease in People living with HIV presented by Nadine Jaschinski on behalf of the RESPOND Study Group. POSTER and PRESENTATION
   
• Prevalence, outcomes, and factors associated with testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among people living with HIV across Europe in the multinational EuroSIDA cohort presented by Wendy Bannister on behalf of the EuroSIDA Study Group. POSTER and PRESENTATION
   

Poster presentation:

• Initial plasma HIV-1 RNA and CD4+ T-cell count are determinants of virological outcomes with initial integrase inhibitor-based regimens: A prospective multinational RESPOND cohort consortium presented by Hortensia Álvarez on behalf of the RESPOND Study Group. POSTER
   

24^th International Workshop on long-term complications of HIV and SARS-CoV-2, 6 – 9 December 2022

Poster presentation:

• Heavy ARV exposure, exhausted/limited ARV options: Predictors and outcomes presented by Amanda Mocroft on behalf of the RESPOND Study Group. POSTER